Call for Abstract

International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, will be organized around the theme “Exploring the Path towards Personalized Medicine”

Personalized Medicine-2013 is comprised of 11 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Personalized Medicine-2013.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Personalized cancer medicine
  • Track 1-2Diabetes- related disease: risk assessment & management
  • Track 1-3Stratified and personalized medicine: New strategies and economic implications
  • Track 1-4Implications of personalized medicine in treatment of HIV
  • Track 1-5Overcoming the challenges in genetic diseases
  • Track 1-6Applications of personalized medicine in rare diseases
  • Track 1-7Personalized genomic medicine
  • Track 2-1Integrated diagnosis
  • Track 2-2Clinical aspects and research
  • Track 2-3Personalized medicine-what it means to the patients?
  • Track 2-4Societal impact of personalized medicine - legal and ethical issues
  • Track 2-5Therapeutics and diagnostics
  • Track 2-6Strategies in the development and application of personalized medicine
  • Track 2-7Personalized medicine in health improvement
  • Track 3-1Gene sequencing
  • Track 3-2SNPs role in drug response
  • Track 3-3Genetic variability
  • Track 3-4Metagenomics
  • Track 4-1Realizing the value of personalized medicine
  • Track 4-2Companion diagnostics vs personalized medicine
  • Track 4-3Personalized medicine-approval process and marketing
  • Track 4-4Personalized medicine-modeling right tools for right persons (IVD)
  • Track 4-5Patents, guidelines, and regulatory affairs for personalized medicine
  • Track 5-1Biomarkers in drug development
  • Track 5-2Types of biomarkers
  • Track 5-3Analytical evaluations of biomarkers
  • Track 5-4Personalizing clinical trials with biomarkers
  • Track 6-1What can nanotechnology do for personalized medicine?
  • Track 6-2Challenges of pharmaceutical nanotechnology in personalized medicine
  • Track 6-3Applications of pharmaceutical nanotools
  • Track 6-4Nanoparticle drug delivery systems
  • Track 7-1Enzyme multiplied immunoassay (EMIT)
  • Track 7-2Radioimmunoassay (RIA)
  • Track 7-3DNA microarray technique
  • Track 7-4Genetic screening and gene profiling methods
  • Track 7-5Personalized medicine in radiology/medical imaging
  • Track 7-6Ex vivo assays for drug sensitivity testing?
  • Track 8-1Translational proteomics
  • Track 8-2Toxicogenomics
  • Track 8-3Computer aided drug design
  • Track 8-4Systems biology
  • Track 9-1Cell based therapy
  • Track 9-2Role of metabolomics in personalized medicine
  • Track 9-3Bioinformatics in personalized medicine
  • Track 9-4Molecular mechanisms in cutting edge development of personalized medicine
  • Track 10-1Translational and clinical trial design
  • Track 10-2GWAS vs systems biology
  • Track 10-3Translational imaging
  • Track 11-1Lifestyle medicine as a treatment option for chronic disease
  • Track 11-2Physical activity and cardiovascular disease. How much is enough?
  • Track 11-3Aerobic & Resistance exercises for patients with diabetes
  • Track 11-4Sleep and disease prevention
  • Track 11-5Intrinsic motivation and health behavior adherence
  • Track 11-6Psychological stress and disease
  • Track 11-7Lifestyle medicine and pain management
  • Track 11-8Lifestyle medicine and cancer prevention